Outlook Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Outlook Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$358K	Sell	638 -3	-0.5%	-$1.92K	0.09%	215
2025 Q4	$434K	Sell	641 -15	-2%	-$10.2K	0.1%	180
2025 Q3	$419K	Sell	656 -193	-23%	-$117K	0.1%	173
2025 Q2	$455K	Sell	849 -17	-2%	-$8.13K	0.12%	162
2025 Q1	$364K	Buy	866 +14	+2%	+$6.08K	0.1%	194
2024 Q4	$352K	Buy	852 +145	+21%	+$63.6K	0.1%	205
2024 Q3	$357K	Buy	707 +64	+10%	+$31.1K	0.1%	192
2024 Q2	$313K	Buy	643 +102	+19%	+$51.2K	0.1%	209
2024 Q1	$292K	Buy	541 +111	+26%	+$60.7K	0.09%	214
2023 Q4	$239K	Buy	+430	New	+$202K	0.08%	199

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Outlook Wealth Advisors's IDXX Position: Q1 2026 in Review

Outlook Wealth Advisors reduced its Idexx Laboratories (IDXX) stake by 0.47% in Q1 2026, selling an estimated $1.92K and leaving 638 shares worth $358K. The position accounts for 0.09% of the portfolio, ranked #215.

Outlook Wealth Advisors first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $455K in Q2 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Outlook Wealth Advisors held 638 shares of Idexx Laboratories worth $358K as of Q1 2026.
Outlook Wealth Advisors sold 3 Idexx Laboratories shares in Q1 2026, an estimated $1.92K.
Idexx Laboratories made up 0.09% of Outlook Wealth Advisors's portfolio in Q1 2026, its #215 holding.
Outlook Wealth Advisors first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
Outlook Wealth Advisors's Idexx Laboratories position peaked at $455K in Q2 2025.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Outlook Wealth Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.